Dermatology

a lot of scissors
Biotech

Quoin shelves 2 assets to build around lead program

Quoin has ended development of two programs, pulling back from the assets as it starts to gear up for the anticipated approval of its lead candidate.
Nick Paul Taylor Jul 29, 2025 10:25am
Novartis

Novartis' ianalumab fails to show promise in dermatology study

Jul 17, 2025 4:28am
puzzle pact

Kaken pens $180M pact for Alumis' lead TYK2 inhibitor in Japan

Mar 25, 2025 6:55am
Rebranding new name billboard

Canadian CRO Innovaderm rebrands to Indero

Mar 11, 2025 5:45am
Graphic image of a man climbing up a latter in front of a beige background with clouds and a blue splotch of sky

Canadian CRO seeks to grow in rheumatology field with new CEO

Feb 4, 2025 3:05pm
Sinking deal terminated sunk deal ends

Affibody regains drug, says ex-ally unable to capitalize on data

Feb 3, 2025 5:18am